Kraig Biocraft Laboratories, Inc. Operating Income Loss

• Kraig Biocraft Laboratories, Inc. showed a decrease of -9.8% in Operating Income Loss from 2024 to 2025.
• This data is from Kraig Biocraft Laboratories, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
• XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q3 2017: -$234.4 thousand | Q1 2018: -$226.6 thousand | Q2 2018: -$152.9 thousand | Q3 2018: -$147.9 thousand | Q1 2019: -$412.0 thousand | Q2 2019: -$335.2 thousand | Q3 2019: -$1.06 million | Q1 2020: -$2.96 million | Q2 2020: -$470.3 thousand | Q3 2020: -$598.5 thousand | Q1 2021: -$665.0 thousand | Q2 2021: -$705.2 thousand | Q3 2021: -$872.5 thousand | Q1 2022: -$545.7 thousand | Q2 2022: -$536.7 thousand | Q3 2022: -$525.3 thousand | Q1 2023: -$486.6 thousand | Q2 2023: -$480.7 thousand | Q3 2023: -$459.4 thousand | Q1 2024: -$448.7 thousand | Q2 2024: -$1.49 million | Q3 2024: -$423.8 thousand | Q1 2025: -$580.5 thousand | Q2 2025: -$637.7 thousand | Q3 2025: -$1.43 million.
• Over the full 16 years of available data (2010 to 2025), Kraig Biocraft Laboratories, Inc.'s Operating Income Loss has declined by 162.3%.
• Historical annual values: Fiscal year 2025: -$3.37 million | Fiscal year 2024: -$3.07 million | Fiscal year 2023: -$2.61 million | Fiscal year 2022: -$2.12 million | Fiscal year 2021: -$2.76 million | Fiscal year 2020: -$4.53 million | Fiscal year 2019: -$2.62 million | Fiscal year 2018: -$959.9 thousand | Fiscal year 2017: -$2.16 million | Fiscal year 2016: -$2.95 million | Fiscal year 2015: -$2.05 million | Fiscal year 2014: -$1.83 million | Fiscal year 2013: -$2.21 million | Fiscal year 2012: -$1.56 million | Fiscal year 2011: -$1.30 million | Fiscal year 2010: -$1.29 million.
• Data sourced from SEC EDGAR public filings as of August 7, 2026.

Last verified: August 7, 2026